New Delhi: Higher doses of oral semaglutide, a widely taken blood sugar medication, have been associated with better control over blood sugar levels and more weight loss than lower doses, scientists have published in the journal The Lancet.
They found that once-daily oral semaglutide taken at 25 milligrams (mg) and 50 mg did a
better job in lowering blood sugar levels and promoting weight loss than the lowest dose of 14 mg.
"Low doses of GLP-1 receptor agonists are really powerful for reducing A1C, or the average glucose in the blood whereas, the higher doses are really good for weight reduction.